ABOUT LINK ALTERNATIF MBL77

Not all patients with CLL demand therapy. Inspite of all modern improvements, the iwCLL even now suggests watchful observation for clients with asymptomatic illness.86 This advice is based on at the very least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104